Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? - PubMed (original) (raw)

Review

Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity?

Joseph C Sun et al. Eur J Immunol. 2009 Aug.

Abstract

Since their discovery three decades ago, NK cells have been classified as cells of the innate immune system. NK cells were shown to respond rapidly and non-specifically to infection, and were thought to act as a functional "bridge" to sustain the early innate immune response until the later adaptive immune responses could be mounted. In light of new findings showing how NK cells possess nearly all of the features of adaptive immunity including memory, we propose the placement of NK cells as an "evolutionary bridge" between innate and adaptive immunity.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no financial or commercial conflict of interest.

Figures

Figure 1

Figure 1

Traditional and revised models of innate and adaptive immunity. Graphs show the immune response against primary and secondary infections. The response of myeloid cells (neutrophils, macrophages, and dendritic cells) is depicted by the green lines. The NK cell response is shown in purple, and the response of B and T cells is shown in blue. The magnitude of the response refers to the qualitative nature of the immune response (i.e. efficacy (protective capability) and effector cytokine production) rather than the absolute number of cells.

Similar articles

Cited by

References

    1. Kiessling R, Klein E, Wigzell H. “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol. 1975;5:112–117. - PubMed
    1. Kiessling R, Klein E, Pross H, Wigzell H. Natural killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol. 1975;5:117–121. - PubMed
    1. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 1986;319:675–678. - PubMed
    1. Ljunggren HG, Karre K. In search of the ’missing self ’: MHC molecules and NK cell recognition. Immunol Today. 1990;11:237–244. - PubMed
    1. Harty JT, Badovinac VP. Shaping and reshaping CD8+T-cell memory. Nat Rev Immunol. 2008;8:107–119. - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources